NeoGenomics, Inc. Earnings Per Share (Diluted)
NeoGenomics, Inc. (NEO) reported Earnings Per Share (Diluted) of -$0.07 per share for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2016-11-07
- NeoGenomics, Inc. earnings per share, diluted for the quarter ending 2022-06-30 was -$0.28, a 148.23% decline year-over-year.
- NeoGenomics, Inc. earnings per share, diluted for the quarter ending 2021-09-30 was -$0.17, a 536.65% decline year-over-year.
- NeoGenomics, Inc. earnings per share, diluted for the quarter ending 2021-06-30 was $0.59.
- NeoGenomics, Inc. earnings per share, diluted for the quarter ending 2020-09-30 was $0.04, a 91.41% increase year-over-year.
- NeoGenomics, Inc. earnings per share, diluted for fiscal 2015 was -$0.04, a 300.00% decline from fiscal 2014.
- NeoGenomics, Inc. earnings per share, diluted for fiscal 2014 was $0.02, a 50.00% decline from fiscal 2013.
- NeoGenomics, Inc. earnings per share, diluted for fiscal 2013 was $0.04.
- NeoGenomics, Inc. earnings per share, diluted for fiscal 2012 was $0.00.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-08-08 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-08-08 | ||
| 2021-09-30 | -$0.17 derived: net income ÷ weighted average shares · filed 2022-11-08 | $0.45 derived: net income ÷ weighted average shares · filed 2022-11-08 | $0.28 derived: net income ÷ weighted average shares · filed 2022-11-08 | |
| 2021-06-30 | $0.59 derived: net income ÷ weighted average shares · filed 2022-08-09 | $0.44 derived: net income ÷ weighted average shares · filed 2022-08-09 | ||
| 2020-09-30 | $0.04 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-11-04 | |
| 2020-06-30 | -$0.06 derived: net income ÷ weighted average shares · filed 2021-08-09 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-08-09 | ||
| 2019-09-30 | $0.02 derived: net income ÷ weighted average shares · filed 2020-10-29 | $0.02 derived: net income ÷ weighted average shares · filed 2020-10-29 | ||
| 2016-09-30 | -$0.07 10-Q · filed 2016-11-07 | -$0.21 10-Q · filed 2016-11-07 | ||
| 2016-06-30 | -$0.07 10-Q · filed 2016-08-05 | -$0.14 10-Q · filed 2016-08-05 | ||
| 2016-03-31 | -$0.07 10-Q · filed 2016-05-10 | |||
| 2015-12-31 | -$0.03 10-K · filed 2016-04-18 | -$0.04 10-K · filed 2016-04-18 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-07 | -$0.02 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-05 | -$0.02 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | -$0.01 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $0.02 10-K · filed 2016-04-18 | $0.02 10-K · filed 2016-04-18 | ||
| 2014-09-30 | -$0.01 10-K · filed 2016-04-18 | $0.00 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $0.01 10-K · filed 2016-04-18 | $0.01 10-Q · filed 2015-07-31 | ||
| 2014-03-31 | $0.00 10-K · filed 2016-04-18 | |||
| 2013-12-31 | $0.02 10-K · filed 2014-02-24 | $0.04 10-K · filed 2016-04-18 | ||
| 2013-09-30 | $0.02 10-K · filed 2014-02-24 | $0.02 10-Q · filed 2013-10-30 | ||
| 2013-06-30 | $0.01 10-K · filed 2014-02-24 | $0.01 10-Q · filed 2013-08-02 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-02-24 | $0.00 10-K · filed 2015-03-03 | ||
| 2012-09-30 | -$0.02 10-K · filed 2014-02-24 | $0.00 10-Q · filed 2013-10-30 | ||
| 2012-06-30 | $0.01 10-K · filed 2014-02-24 | $0.02 10-Q · filed 2013-08-02 | ||
| 2012-03-31 | $0.01 10-K · filed 2014-02-24 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-24 | -$0.03 10-K · filed 2014-02-24 | ||
| 2011-09-30 | $0.00 10-K · filed 2014-02-24 | -$0.03 10-Q · filed 2012-11-05 | ||
| 2011-06-30 | -$0.01 10-K · filed 2014-02-24 | -$0.03 10-Q/A · filed 2012-08-15 | ||
| 2011-03-31 | -$0.02 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |